Clinical Use Studies Also Show 94-Percent Score for Ease-of-Use, Ergonomics and Performance Tests

Authorizes medical product company to continue distributing BabyLance safety heelsticks and SurgiLance safety lancets in Canada.

Case studies compared alginate, hydrocolloid, film, foam, and surgical dressings.

MediPurpose Receives U.S. FDA 510(k) Clearance for Redesigned babyLance Safety Heelstick

babyLance heelstick reinvention process prioritized harmony between end-user ergonomic requirements and design team innovation.

Shawn McKeever brings more than 10 years of medical device experience to MediPurpose.

Concise guide to wound care simplifies wound treatment through Wound Management Algorithm.

An independent laboratory has found that BIOGUARD barrier gauze dressings with Quick-Med's novel NIMBUS antimicrobial technology exhibit high antiviral efficacy against the H1N1 virus.

Quick-Med Technologies, Inc. (OTCBB: QMDT) announced today that The Wall Street Transcript (TWST) has included an interview with the Company's CEO, J. Ladd Greeno, in the publication's latest Pharmaceutical Report.

Quick-Med, a pioneer in advanced antimicrobial technologies for medical and consumer applications, announced today that USPTO and the World Intellectual Property Organization have published Company patent applications covering Disinfectant Alcohol-Soluble Quaternary Ammonium Polymers.